BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30822274)

  • 1. AIP and MEN1 mutations and AIP immunohistochemistry in pituitary adenomas in a tertiary referral center.
    Daly AF; Cano DA; Venegas-Moreno E; Petrossians P; Dios E; Castermans E; Flores-Martínez A; Bours V; Beckers A; Soto-Moreno A
    Endocr Connect; 2019 Apr; 8(4):338-348. PubMed ID: 30822274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients.
    Cazabat L; Bouligand J; Salenave S; Bernier M; Gaillard S; Parker F; Young J; Guiochon-Mantel A; Chanson P
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E663-70. PubMed ID: 22319033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical, pathological, and genetic features of familial isolated pituitary adenomas.
    Beckers A; Daly AF
    Eur J Endocrinol; 2007 Oct; 157(4):371-82. PubMed ID: 17893250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families.
    Daly AF; Vanbellinghen JF; Khoo SK; Jaffrain-Rea ML; Naves LA; Guitelman MA; Murat A; Emy P; Gimenez-Roqueplo AP; Tamburrano G; Raverot G; Barlier A; De Herder W; Penfornis A; Ciccarelli E; Estour B; Lecomte P; Gatta B; Chabre O; Sabaté MI; Bertagna X; Garcia Basavilbaso N; Stalldecker G; Colao A; Ferolla P; Wémeau JL; Caron P; Sadoul JL; Oneto A; Archambeaud F; Calender A; Sinilnikova O; Montañana CF; Cavagnini F; Hana V; Solano A; Delettieres D; Luccio-Camelo DC; Basso A; Rohmer V; Brue T; Bours V; Teh BT; Beckers A
    J Clin Endocrinol Metab; 2007 May; 92(5):1891-6. PubMed ID: 17244780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don't forget MEN1 genetic analysis.
    Cuny T; Pertuit M; Sahnoun-Fathallah M; Daly A; Occhi G; Odou MF; Tabarin A; Nunes ML; Delemer B; Rohmer V; Desailloud R; Kerlan V; Chabre O; Sadoul JL; Cogne M; Caron P; Cortet-Rudelli C; Lienhardt A; Raingeard I; Guedj AM; Brue T; Beckers A; Weryha G; Enjalbert A; Barlier A
    Eur J Endocrinol; 2013 Apr; 168(4):533-41. PubMed ID: 23321498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three Novel MEN1 Variants in AIP-Negative Familial Isolated Pituitary Adenoma Patients.
    Yarman S; Tuncer FN; Serbest E
    Pathobiology; 2019; 86(2-3):128-134. PubMed ID: 30630164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sporadic pituitary adenomas: the role of germline mutations and recommendations for genetic screening.
    Iacovazzo D; Hernández-Ramírez LC; Korbonits M
    Expert Rev Endocrinol Metab; 2017 Mar; 12(2):143-153. PubMed ID: 30063429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary Disease in
    Bilbao Garay I; Daly AF; Egaña Zunzunegi N; Beckers A
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32604740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.
    Beckers A; Aaltonen LA; Daly AF; Karhu A
    Endocr Rev; 2013 Apr; 34(2):239-77. PubMed ID: 23371967
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Trofimiuk-Müldner M; Domagała B; Sokołowski G; Skalniak A; Hubalewska-Dydejczyk A
    Front Endocrinol (Lausanne); 2023; 14():1098367. PubMed ID: 36843582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: The roles of AIP and GPR101 in familial isolated pituitary adenomas (FIPA).
    Vasilev V; Daly AF; Trivellin G; Stratakis CA; Zacharieva S; Beckers A
    Endocr Relat Cancer; 2020 Aug; 27(8):T77-T86. PubMed ID: 32083999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline mutations of AIP gene in somatotropinomas resistant to somatostatin analogues.
    Oriola J; Lucas T; Halperin I; Mora M; Perales MJ; Alvarez-Escolá C; Paz de MN; Díaz Soto G; Salinas I; Julián MT; Olaizola I; Bernabeu I; Marazuela M; Puig-Domingo M
    Eur J Endocrinol; 2013 Jan; 168(1):9-13. PubMed ID: 23038625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AIP-mutated acromegaly resistant to first-generation somatostatin analogs: long-term control with pasireotide LAR in two patients.
    Daly AF; Rostomyan L; Betea D; Bonneville JF; Villa C; Pellegata NS; Waser B; Reubi JC; Waeber Stephan C; Christ E; Beckers A
    Endocr Connect; 2019 Apr; 8(4):367-377. PubMed ID: 30851160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial isolated pituitary adenomas (FIPA) and mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.
    Daly AF; Beckers A
    Endocrinol Metab Clin North Am; 2015 Mar; 44(1):19-25. PubMed ID: 25732638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study.
    Daly AF; Tichomirowa MA; Petrossians P; Heliövaara E; Jaffrain-Rea ML; Barlier A; Naves LA; Ebeling T; Karhu A; Raappana A; Cazabat L; De Menis E; Montañana CF; Raverot G; Weil RJ; Sane T; Maiter D; Neggers S; Yaneva M; Tabarin A; Verrua E; Eloranta E; Murat A; Vierimaa O; Salmela PI; Emy P; Toledo RA; Sabaté MI; Villa C; Popelier M; Salvatori R; Jennings J; Longás AF; Labarta Aizpún JI; Georgitsi M; Paschke R; Ronchi C; Valimaki M; Saloranta C; De Herder W; Cozzi R; Guitelman M; Magri F; Lagonigro MS; Halaby G; Corman V; Hagelstein MT; Vanbellinghen JF; Barra GB; Gimenez-Roqueplo AP; Cameron FJ; Borson-Chazot F; Holdaway I; Toledo SP; Stalla GK; Spada A; Zacharieva S; Bertherat J; Brue T; Bours V; Chanson P; Aaltonen LA; Beckers A
    J Clin Endocrinol Metab; 2010 Nov; 95(11):E373-83. PubMed ID: 20685857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of
    Tuncer FN; Çiftçi Doğanşen S; Serbest E; Tanrıkulu S; Ekici Y; Bilgiç B; Yarman S
    Genet Test Mol Biomarkers; 2018 Dec; 22(12):702-708. PubMed ID: 30461320
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence of AIP mutations in a large series of sporadic Italian acromegalic patients and evaluation of CDKN1B status in acromegalic patients with multiple endocrine neoplasia.
    Occhi G; Trivellin G; Ceccato F; De Lazzari P; Giorgi G; Demattè S; Grimaldi F; Castello R; Davì MV; Arnaldi G; Salviati L; Opocher G; Mantero F; Scaroni C
    Eur J Endocrinol; 2010 Sep; 163(3):369-76. PubMed ID: 20530095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations.
    Georgitsi M; Raitila A; Karhu A; Tuppurainen K; Mäkinen MJ; Vierimaa O; Paschke R; Saeger W; van der Luijt RB; Sane T; Robledo M; De Menis E; Weil RJ; Wasik A; Zielinski G; Lucewicz O; Lubinski J; Launonen V; Vahteristo P; Aaltonen LA
    Proc Natl Acad Sci U S A; 2007 Mar; 104(10):4101-5. PubMed ID: 17360484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Very low frequency of germline GPR101 genetic variation and no biallelic defects with AIP in a large cohort of patients with sporadic pituitary adenomas.
    Lecoq AL; Bouligand J; Hage M; Cazabat L; Salenave S; Linglart A; Young J; Guiochon-Mantel A; Chanson P; Kamenický P
    Eur J Endocrinol; 2016 Apr; 174(4):523-30. PubMed ID: 26792934
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.